Cytek IPO Presentation Deck

Our FSP Platform Allows Us to Address the Broader Cell Analysis Market Agilent BIO-RAD Technologies FLUIDIGM SONY BECKMAN $3.0B Cell ID COULTER Milteny! Biotec $8B Initial TAM (Cell Analysis Market in 2019 Addressable by Flow Cytometry) BD Thermo Fisher SCIENTIFIC Marine Biology $1.9B Cell Proliferation $1.6B Cell Counting & QC $1.0B Single Cell Analysis $2.4B Cell Viability $8B Additional TAM (Cell Analysis Market in 2019 Not Currently Addressable by Flow Cytometry) $23B Long-Term TAM (Total Cell Analysis Market in 2024) Water Supply Contamination $2.4B Cell Signaling ES $1.3B Cell Interaction Alternative Biofuels $1.3B Target ID CYTEK $1.1B Cell Structure 10

View entire presentation